U.S. Market for Interventional Cardiology 2009
In 2008, the U.S. market for interventional cardiology was valued at $US 4.6 billion. This value represents drug-eluting stents, PTCA balloons, coronary closure devices, bare-metal stents, embolic protection devices, interventional guidewires, diagnostic catheters, intravascular ultrasound (IVUS) catheters, and interventional catheters. Over the forecast period, the market is predicted to decrease in value due to limited sales of drug-eluting stents.
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
1.1 MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
1.2 BARE-METAL AND DRUG-ELUTING STENTS
1.3 PTCA AND CUTTING BALLOONS
1.4 BALLOON-INFLATION SYRINGES AND ANGIOPLASTY KITS
1.5 INTERVENTIONAL CATHETERS
1.6 INTERVENTIONAL GUIDEWIRES
1.7 EMBOLIC PROTECTION DEVICES
1.8 ATHERECTOMY DEVICES
1.9 THROMBECTOMY DEVICES
1.10 CHRONIC TOTAL OCCLUSION CROSSERS
1.11 INTRODUCER SHEATHS.
1.12 VASCULAR CLOSURE DEVICES.
1.13 DIAGNOSTIC CORONARY CATHETERS AND GUIDEWIRES
1.14 FRACTIONAL FLOW RESERVE GUIDEWIRES
1.15 IVUS CATHETERS
1.16 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
1.17 VULNERABLE PLAQUE DEVICES
1.18 PFO, ASD AND VSD DEVICES
1.19 PERCUTANEOUS MITRAL VALVE REPAIR DEVICES.
1.20 AORTIC HEART VALVE REPLACEMENT DEVICES.
1.21 LEADING COMPETITORS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
2.2.1 Step 1: Project Initiation & Team Selection
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
2.2.4 Step 4: Performing Primary Research
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
2.2.6 Step 6: Market Forecast and Analysis
2.2.7 Step 7: Identify Strategic Opportunities
2.2.8 Step 8: Final Review and Market Release
2.2.9 Step 9: Customer Feedback and Market Monitoring
U.S MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
3.1 INTRODUCTION
3.2 OVERVIEW OF THE MARKET
3.3 MARKET SEGMENTED BY DEVICE TYPE
3.3.1 Effects of the Economic Crisis
3.4 TREND ANALYSIS BY MARKET SEGMENT
3.5 MARKET DRIVERS
3.6 MARKET LIMITERS
3.7 COMPETITIVE ANALYSIS
3.8 MERGERS AND ACQUISITIONS
BARE-METAL AND DRUG-ELUTING STENTS
4.1 INTRODUCTION
4.2 POPULATION AT RISK
4.3 PROCEDURE NUMBERS
4.4 MARKET ANALYSIS & FORECAST
4.4.1 Units Sold by Type
4.4.2 Bare-Metal Stent Market
4.4.2.1 Bare-Metal Stent Market Drivers
4.4.2.2 Bare-Metal Stent Market Limiters
4.4.3 Drug-Eluting Stent Market
4.4.3.1 Drug-Eluting Stent Market Drivers
4.4.3.2 Drug-Eluting Stent Market Limiters
4.4.4 Stents in Development
4.4.4.1 Bioabsorbable Stents
4.4.4.2 Bifurcated Stents
4.5 STENT MARKET BY DELIVERY PLATFORM.
4.6 STENT MARKET BY SIZE
4.7 COMPETITIVE ANALYSIS
4.7.1 Bare-Metal Stents
4.7.2 Drug-Eluting Stents
4.7.3 Potential New Market Participants
PTCA AND CUTTING BALLOON CATHETERS
5.1 INTRODUCTION
5.1.1 The Problem of Restenosis
5.1.2 Conventional and Cutting Balloons
5.2 MARKET OVERVIEW
5.3 MARKET FOR PTCA BALLOONS
5.3.1 Units Sold.
5.3.2 Market Analysis & Forecast
5.4 MARKET FOR CUTTING BALLOONS
5.4.1 Device Penetration
5.4.2 Market Analysis & Forecast
5.5 MARKET DRIVERS AND LIMITERS
5.5.1 Market Drivers
5.5.2 Market Limiters.
5.6 NEW TECHNOLOGIES – DRUG-COATED BALLOON CATHETERS
5.7 COMPETITIVE ANALYSIS
5.7.1 PTCA Balloon Catheters
5.7.2 Cutting Balloon Catheters
BALLOON-INFLATION SYRINGES
6.1 INTRODUCTION
6.2 MARKET ANALYSIS & FORECAST
6.3 MARKET DRIVERS AND LIMITERS
6.3.1 Market Drivers
6.3.2 Market Limiters
6.4 COMPETITIVE ANALYSIS
ANGIOPLASTY KITS
7.1 INTRODUCTION
7.2 MARKET ANALYSIS & FORECAST
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS
INTERVENTIONAL CATHETERS
8.1 INTRODUCTION
8.2 UNITS SOLD
8.3 MARKET ANALYSIS & FORECAST
8.3.1 Interventional Guiding Catheters Market.
8.3.2 Interventional Support Catheters Market
8.4 MARKET DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS
INTERVENTIONAL GUIDEWIRES
9.1 INTRODUCTION
9.1.1 Conventional and Specialty Guidewires
9.1.2 Material and Fabrication
9.2 UNITS SOLD
9.3 MARKET ANALYSIS & FORECAST
9.3.1 Conventional Guidewires Market
9.3.2 Specialized Guidewires Market
9.4 MARKET DRIVER AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS
EMBOLIC PROTECTION DEVICES
10.1 INTRODUCTION
10.1.1 Saphenous Vein Grafts
10.1.2 Protection Mechanism
10.2 MARKET ANALYSIS & FORECAST
10.3 PENETRATION RATE
10.4 MARKET DRIVERS AND LIMITERS
10.4.1 Market Drivers.
10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS
CORONARY ATHERECTOMY DEVICES
11.1 INTRODUCTION
11.1.1 Atherectomy
11.1.2 Technologies
11.1.2.1 Mechanical
11.1.2.2 Laser
11.1.2.3 Directional Coronary Atherectomy (DCA)
11.2 MARKET ANALYSIS & FORECAST
11.3 PENETRATION RATE
11.4 MARKET DRIVERS AND LIMITERS
11.4.1 Market Drivers.
11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS
THROMBECTOMY DEVICES
12.1 INTRODUCTION
12.1.1 Thrombosis and Drug-Eluting Stents
12.2 MARKET ANALYSIS & FORECAST
12.3 PENETRATION RATE
12.4 MARKET DRIVERS AND LIMITERS
12.4.1 Market Drivers.
12.4.2 Market Limiters
12.5 COMPETITIVE ANALYSIS
CHRONIC TOTAL OCCLUSION CROSSERS
13.1 INTRODUCTION
13.2 POTENTIAL MARKET.
13.3 MARKET ANALYSIS & FORECAST
13.4 PENETRATION RATE
13.5 MARKET DRIVERS AND LIMITERS
13.5.1 Market Drivers.
13.5.2 Market Limiters
13.6 COMPETITIVE ANALYSIS
INTRODUCER SHEATHS
14.1 INTRODUCTION
14.2 MARKET ANALYSIS & FORECAST
14.2.1 Units Sold
14.2.2 Market Analysis & Forecast
14.3 MARKET DRIVERS AND LIMITERS
14.3.1 Market Drivers.
14.3.2 Market Limiters
14.4 COMPETITIVE ANALYSIS
VASCULAR CLOSURE DEVICES
15.1 INTRODUCTION
15.1.1 Manual Compression
15.1.2 Invasive and Non-Invasive Devices
15.2 MARKET ANALYSIS & FORECAST
15.3 PENETRATION RATE
15.3.1 Diagnostic Procedures
15.3.2 Interventional Procedures
15.4 MARKET DRIVERS AND LIMITERS
15.4.1 Market Drivers.
15.4.2 Market Limiters
15.5 COMPETITIVE ANALYSIS
DIAGNOSTIC CATHETERS AND GUIDEWIRES
16.1 INTRODUCTION
16.1.1 Coronary Angiography
16.2 MARKET ANALYSIS & FORECAST
16.3 DIAGNOSTIC CATHETERS
16.3.1 Market Analysis & Forecast
16.3.2 Units Sold
16.3.3 Units Sold Segmented by Size
16.3.4 Competitive Analysis.
16.4 DIAGNOSTIC GUIDEWIRES
16.4.1 Market Analysis & Forecast
16.4.2 Units Sold
16.4.3 Competitive Analysis.
16.5 FRACTIONAL FLOW RESERVE (FFR) GUIDEWIRES
16.5.1 Market Analysis and Forecast
16.5.2 Units Sold
16.5.3 Competitive Analysis.
16.6 MARKET DRIVERS AND LIMITERS
16.6.1 Market Drivers.
16.6.2 Market Limiters
IVUS CATHETERS
17.1 INTRODUCTION
17.1.1 Pre-Stenting Applications
17.1.2 Post-Stenting Applications.
17.1.3 IVUS Console Penetration.
17.2 MARKET ANALYSIS & FORECAST
17.3 PENETRATION RATE
17.4 MARKET DRIVERS AND LIMITERS
17.4.1 Market Drivers.
17.4.2 Market Limiters
17.5 COMPETITIVE ANALYSIS
OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
18.1 INTRODUCTION
18.2 POTENTIAL MARKET.
18.3 MARKET ANALYSIS AND FORECAST
18.4 MARKET DRIVERS AND LIMITERS
18.4.1 Market Drivers.
18.4.2 Market Limiters
18.5 COMPETITIVE ANALYSIS
VULNERABLE PLAQUE DEVICES
19.1 INTRODUCTION
19.1.1 Vulnerable Plaque Screening Technologies
19.1.1.1 Intravascular Ultrasound (IVUS)
19.1.1.2 Optical Coherence Tomography (OCT)
19.1.1.3 Raman Spectroscopy
19.1.1.4 Near Infrared (NIR) Spectroscopy
19.1.1.5 Thermography
19.1.1.6 Intravascular Magnetic Resonance Imaging (IVMRI)
19.1.1.7 Computed Tomography (CT)
19.1.2 Potential Vulnerable Plaque Treatments
19.1.2.1 Stents
19.1.2.2 Pharmaceuticals
19.1.2.3 Photodynamic Therapies
19.1.2.4 Cryotherapy
19.2 TARGET POPULATION
19.3 MARKET ANALYSIS AND FORECAST
19.3.1 Total Market Potential.
19.3.2 Market Forecast
19.3.3 Screening Market
19.3.4 Treatment Market
19.4 COMPETITIVE ANALYSIS
PFO DEVICES
20.1 INTRODUCTION
20.2 MARKET ANALYSIS AND FORECAST
20.3 MARKET DRIVERS AND LIMITERS
20.3.1 Market Drivers.
20.3.2 Market Limiters
20.4 COMPETITIVE ANALYSIS
ASD AND VSD DEVICES
21.1 INTRODUCTION
21.1.1 Atrial Septal Defect (ASD)248
21.1.2 Ventricular Septal Defect (VSD)248
21.2 MARKET ANALYSIS AND FORECAST
21.3 MARKET DRIVERS AND LIMITERS
21.3.1 Market Drivers.
21.3.2 Market Limiters
21.4 COMPETITIVE ANALYSIS
PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
22.1 INTRODUCTION
22.1.1 Percutaneous Mitral Valve Repair (PMVR)
22.2 TARGET POPULATION
22.3 POTENTIAL MARKET.
22.4 MARKET DRIVERS AND LIMITERS
22.4.1 Market Drivers.
22.4.2 Limiters
22.5 COMPETITIVE ANALYSIS
PERCUTANEOUS AORTIC HEART VALVE REPLACEMENT DEVICES
23.1 INTRODUCTION
23.2 MARKET ANALYSIS AND FORECAST
23.2.1 Revenue Probability
23.3 MARKET DRIVERS AND LIMITERS
23.3.1 Market Drivers.
23.3.2 Market Limiters
23.4 COMPETITIVE ANALYSIS
LIST OF FIGURES
EXECUTIVE SUMMARY
RESEARCH METHODOLOGY.
U.S MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES.
Figure 3-1: Market for Interventional Cardiology Segmented by Device Type, U.S., 2005 – 2015
Figure 3-2: Trend Analysis by Market Segment, Growth Rates of the Market for Interventional Cardiology, U.S., 2005 – 2015
Figure 3-3: Market Drivers, Market for Interventional Cardiology, U.S, 2008
Figure 3-4: Market Limiters, Market for Interventional Cardiology, U.S., 2008
Figure 3-5: Leading Competitors by Market Segment, U.S Market for Interventional Cardiology, 2008
BARE-METAL AND DRUG-ELUTING STENTS.
Figure 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005 – 2015
Figure 4-2: Angiography and Angioplasty Procedures, U.S., 2005 – 2015
Figure 4-3: Market for Coronary Stents by Type, U.S., 2005 – 2015.
Figure 4-4: Units Sold, Market for Coronary Stents, U.S., 2005 – 2015
Figure 4-5: Coronary Stent Units by Type, U.S., 2005 – 2015
Figure 4-6: Market for Bare-Metal Stents, U.S., 2005 – 2015
Figure 4-7: Market Drivers and Limiters, Market for Bare-Metal Stents, U.S., 2008
Figure 4-8: Market for Drug-Eluting Stents, U.S., 2005 – 2015
Figure 4-9: Market Drivers and Limiters, Market for Drug-Eluting Stents, U.S., 2008
Figure 4-10: Coronary Stent Platforms in Development Not Approved by the FDA, 2008.
Figure 4-11: Potential Market for Bioabsorbable Stents, U.S., 2013 – 2015
Figure 4-12: Potential Market for Bifurcated Stents, U.S., 2010 – 2015
Figure 4-13: Market for Coronary Stents by Delivery Platform, Units Sold, U.S., 2005 – 2015
Figure 4-14: Market for Coronary Stents by Size, U.S., 2008
Figure 4-15: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
Figure 4-16: Leading Competitors, U.S Market for Drug-Eluting Stents, 2008
PTCA AND CUTTING BALLOON CATHETERS
Figure 5-1: Market for PTCA and Cutting Balloon Catheters, U.S., 2005 – 2015
Figure 5-2: Units Sold, Market for PTCA Balloon Catheters, U.S., 2005 – 2015
Figure 5-3: Market for PTCA Balloon Catheters, U.S., 2005 – 2015
Figure 5-4: Units Sold, Market for Cutting Balloon Catheters, U.S., 2005 – 2015
Figure 5-5: Market for Cutting Balloon Catheters, U.S., 2005 – 2015
Figure 5-6: Market Drivers and Limiters, U.S Market for PTCA and Cutting Balloon Catheters, 2008
Figure 5-7: Leading Competitors, Market for PTCA Balloon Catheters, U.S., 2008
Figure 5-8: Leading Competitors, Market for PTCA Balloon Catheters, U.S., 2008
BALLOON-INFLATION SYRINGES.
Figure 6-1: Market for Balloon-Inflation Syringes, U.S., 2005 – 2015
Figure 6-2: Market Drivers and Limiters, U.S Market for Balloon-Inflation Syringes, 2008
Figure 6-3: Leading Competitors, Market for Balloon-Inflation Syringes, U.S., 2008
ANGIOPLASTY KITS
Figure 7-1: Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
Figure 7-2: Market Drivers and Limiters, Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
Figure 7-3: Leading Competitors, Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
INTERVENTIONAL CATHETERS
Figure 8-1: Units Sold, Market for Interventional Coronary Catheters, U.S., 2005 – 2015
Figure 8-2: Market for Interventional Coronary Catheters by Device Type, U.S., 2005 – 2015
Figure 8-3: Market for Interventional Guiding Catheters, U.S., 2005 – 2015
Figure 8-4: Market for Interventional Support Catheters, U.S., 2005 – 2015
Figure 8-5: Market Drivers and Limiters, Market for Interventional Coronary Catheters, U.S., 2008
Figure 8-6: Leading Competitors, Market for Interventional Coronary Catheters, U.S., 2008
INTERVENTIONAL GUIDEWIRES
Figure 9-1: Units Sold, Market for Interventional Coronary Guidewires, U.S., 2005 – 2015
Figure 9-2: Market for Interventional Coronary Guidewires by Device Type, U.S., 2005 – 2015
Figure 9-3: Market for Interventional Coronary Conventional Guidewires, U.S., 2005 – 2015
Figure 9-4: Market for Interventional Coronary Specialized Guidewires, U.S., 2005 – 2015
Figure 9-5: Market Drivers and Limiters, Market for Interventional Coronary Guidewires, U.S., 2008
Figure 9-6: Leading Competitors, Market for Interventional Coronary Guidewires, U.S., 2008
EMBOLIC PROTECTION DEVICES
Figure 10-1: Market for Coronary Embolic Protection Devices, U.S., 2005 – 2015132
Figure 10-2: Penetration Rate, Market for Coronary Embolic Protection Devices, U.S., 2005 – 2015
Figure 10-3: Market Drivers and Limiters, Market for Coronary Embolic Protection Devices, U.S., 2008
Figure 10-4: Leading Competitors, Market for Coronary Embolic Protection Devices, U.S., 2008
CORONARY ATHERECTOMY DEVICES
Figure 11-1: Market for Coronary Atherectomy Devices, U.S., 2005 – 2015
Figure 11-2: Penetration Rate, Market for Coronary Atherectomy Devices, U.S., 2005 – 2015
Figure 11-3: Market Drivers and Limiters, U.S Market for Coronary Atherectomy Devices, 2008
Figure 11-4: Leading Competitors, Market for Coronary Atherectomy Devices, U.S., 2008
THROMBECTOMY DEVICES
Figure 12-1: Market for Coronary Thrombectomy Devices, U.S., 2005 – 2015
Figure 12-2: Penetration Rate, Market for Coronary Thrombectomy Devices, U.S., 2005 – 2015
Figure 12-3: Market Drivers and Limiters, Market for Coronary Thrombectomy Devices, U.S., 2008
Figure 12-4: Leading Competitors, Market for Coronary Thrombectomy Devices, U.S., 2008
CHRONIC TOTAL OCCLUSION CROSSERS
Figure 13-1: Potential Market for Chronic Total Occlusion Crossers, Market for Interventional Cardiology, U.S., 2005 – 2015
Figure 13-2: Market for Coronary Chronic Total Occlusion Crossers, U.S., 2005 – 2015
Figure 13-3: Penetration Rate, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2005 – 2015
Figure 13-4 Market Drivers and Limiters, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2008
Figure 13-5: Leading Competitors, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2008
INTRODUCER SHEATHS
Figure 14-1: Units Sold, Coronary Market for Introducer Sheaths, U.S., 2005 – 2015
Figure 14-2: Coronary Market for Introducer Sheaths, U.S., 2005 – 2015
Figure 14-3: Market Drivers and Limiters, U.S Market for Introducer Sheaths, 2008
Figure 14-4: Leading Competitors, Market for Introducer Sheaths, U.S., 2008
VASCULAR CLOSURE DEVICES
Figure 15-1: Market for Coronary Vascular Closure Devices (Invasive and Non- Invasive), U.S., 2005 – 2015
Figure 15-2: Penetration Rate, Market for Coronary Vascular Closure Devices (Invasive and Non-Invasive), U.S., 2005 – 2015
Figure 15-3: Market Drivers and Limiters, Market for Coronary Vascular Closure Devices, U.S., 2008
Figure 15-4: Leading Competitors, Market for Coronary Vascular Closure Devices, U.S., 2008
DIAGNOSTIC CATHETERS AND GUIDEWIRES
Figure 16-1: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005 – 2015
Figure 16-2: Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Figure 16-3: Units Sold, Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Figure 16-4: Units Sold Segmented by Size, Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Figure 16-5: Leading Competitors, Market for Diagnostic Coronary Catheters, U.S., 2008
Figure 16-6: Market for Diagnostic Coronary Guidewires, U.S., 2005 – 2015
Figure 16-7: Units Sold, Market for Diagnostic Coronary Guidewires, U.S., 2005 – 2015
Figure 16-8: Leading Competitors, Market for Diagnostic Coronary Guidewires, U.S., 2008
Figure 16-9: Market for FFR Guidewires, U.S., 2005 – 2015.
Figure 16-10: Units Sold, Market for FFR Guidewires, U.S., 2005 – 2015
Figure 16-11: Leading Competitors in the FFR Guidewire Market, U.S., 2008
Figure 16-12: Market Drivers and Limiters, Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2008
IVUS CATHETERS
Figure 17-1: IVUS Console Penetration Rate, U.S., 2005 – 2015
Figure 17-2: Market for IVUS Catheters, U.S., 2005 – 2015
Figure 17-3: Penetration Rate, Market for IVUS Catheters, U.S., 2005 – 2015
Figure 17-4: Market Drivers and Limiters, Market for IVUS Catheters, U.S., 2008210
Figure 17-5: Leading Competitors, Market for IVUS Catheters, U.S., 2005 – 2015211
OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
Figure 18-1: Potential Market for OCT Catheters, U.S., 2010 – 2015.
Figure 18-2: Potential Market for OCT Consoles, U.S., 2010 – 2015
Figure 18-3: Potential Market for Coronary OCT Devices, U.S., 2010 – 2015
Figure 18-4: Market Drivers and Limiters in the OCT Market, U.S., 2008
VULNERABLE PLAQUE DEVICES
Figure 19-1: Target Population, Potential Market for Vulnerable Plaque Screening, U.S., 2005 – 2015
Figure 19-2: Maximum Potential Market for Vulnerable Plaque, U.S., 2010 – 2015
Figure 19-3: Forecasted Potential Market for Vulnerable Plaque, U.S., 2010 – 2015
Figure 19-4: Forecasted Potential Market for Vulnerable Plaque Screening, U.S., 2010 – 2015
Figure 19-5 : Forecasted Potential Market for Vulnerable Plaque Treatment, U.S., 2010 – 2015
Figure 19-6: Potential Competitors in the U.S Market for Vulnerable Plaque Devices
PFO DEVICES
Figure 20-1: Market for PFO Devices, U.S., 2005 – 2015
Figure 20-2: Market Drivers and Limiters in the PFO Devices Market, U.S., 2008244
Figure 20-3: Leading Competitors, Market for PFO Devices, U.S., 2008
ASD AND VSD DEVICES
Figure 21-1: Market for ASD and VSD Devices, U.S., 2005 – 2015
Figure 21-2: Market Drivers and Limiters in the ASD and VSD Devices Market, U.S., 2008
Figure 21-3: Leading Competitors, Market for ASD and VSD Devices, U.S., 2008253
PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
Figure 22-1: Target Population, Potential Market for PMVR Devices, U.S., 2010 – 2015
Figure 22-2: Potential Market for Percutaneous Mitral Valve Repair Devices, U.S., 2010 – 2015
Figure 22-3: Market Drivers and Limiters in the PVMR Market, U.S., 2008
Figure 22-4: Market Players, Potential Market for PMVR Devices, U.S., 2010 – 2015
PERCUTANEOUS AORTIC HEART VALVE REPLACEMENT DEVICES
Figure 23-1: Potential Market for Aortic Valve Replacement Devices, Weighted Average Scenario, U.S., 2008 – 2015
Figure 23-2: Total Revenue, Potential Market for Aortic Valve Replacement Devices, Weighted Average Scenario, U.S., 2011 – 2015
Figure 23-3: Market Drivers and Limiters in the Aortic Valve Replacement Market, U.S., 2008
Figure 23-4: Market Players, Potential Market for PAVR Devices, U.S., 2010 – 2015
LIST OF CHARTS
EXECUTIVE SUMMARY
Chart 1-1: Market for Interventional Cardiology Devices, U.S., 2008
Chart 1-2: Market for Coronary Stents, U.S., 2005 – 2015
Chart 1-3: Coronary Atherectomy Devices Market, U.S., 2005 – 2015
Chart 1-4: Coronary CTO Crosser Market, U.S., 2005 – 2015
Chart 1-5: Coronary Vascular Closure Devices, U.S., 2005 – 2015
Chart 1-6: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005 – 2015
Chart 1-7: Penetration Rate of FFR Guidewires in PCI Procedures, U.S., 2005 - 2015
Chart 1-8: Number of IVUS Catheter Units Sold, U.S., 2005 – 2015
Chart 1-9: Optical Coherence Tomography Catheter Market, U.S., 2010 – 2015
Chart 1-10: Leading Competitors, Market for Interventional Cardiology, U.S., 2008
RESEARCH METHODOLOGY.
U.S MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES.
Chart 3-1: Market for Interventional Cardiology, U.S., 2005 – 2015
Chart 3-2: Market for Interventional Cardiology Segmented by Device Type, U.S., 2008
Chart 3-3: Market for Interventional Cardiology Segmented by Device Type, U.S., 2015
Chart 3-4: Trend Analysis for Selected Markets for Interventional Cardiology Devices, U.S., 2005 – 2015
Chart 3-5: Leading Competitors, Market for Interventional Cardiology, U.S., 2008
BARE-METAL AND DRUG-ELUTING STENTS.
Chart 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005 – 2015
Chart 4-2: Age Group Most Likely to Undergo Cardiac Intervention: 60 to 69 Years Old, U.S., 2005 – 2015
Chart 4-3: Angioplasty and Angiography Procedures, U.S., 2005 – 2015
Chart 4-4: Market for Coronary Stents by Type, U.S., 2005 – 2015
Chart 4-5: Coronary Stent Units by Type, U.S., 2005 – 2015
Chart 4-6: Market for Bare-Metal Stents, U.S., 2005 – 2015.
Chart 4-7: Market for Drug-Eluting Stents, U.S., 2005 – 2015.
Chart 4-8: Penetration Rate for Bioabsorbable Stents, U.S., 2013 – 2015
Chart 4-9: Penetration Rate for Bifurcated Stents, U.S., 2010 – 2015
Chart 4-10: Market for Coronary Stents by Delivery Platform, Units Sold, U.S., 2005 – 2015
Chart 4-11: Market for Coronary Stents by Size, U.S., 2008
Chart 4-12: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
Chart 4-13: Leading Competitors, Market for Drug-Eluting Stents, U.S., 2008
PTCA AND CUTTING BALLOON CATHETERS
Chart 5-1: Market for PTCA and Cutting Balloon Catheters, U.S., 2005 – 2015
Chart 5-2: Market for PTCA Balloon Catheters, U.S., 2005 – 2015
Chart 5-3: Market for Cutting Balloon Catheters, U.S., 2005 – 2015.
Chart 5-4: Leading Competitors, Market for PTCA Balloon Catheters, U.S., 200896
BALLOON-INFLATION SYRINGES.
Chart 6-1: Market for Balloon-Inflation Syringes, U.S., 2005 – 2015.
Chart 6-2: Leading Competitors, Market for Balloon-Inflation Syringes, U.S., 2008
ANGIOPLASTY KITS
Chart 7-1: Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
Chart 7-2: Leading Competitors, Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
INTERVENTIONAL CATHETERS
Chart 8-1: Market for Interventional Coronary Catheters by Device Type, U.S., 2005 – 2015
Chart 8-2: Leading Competitors, Market for Interventional Coronary Catheters, U.S., 2008
INTERVENTIONAL GUIDEWIRES
Chart 9-1: Units Sold, Market for Interventional Coronary Guidewires, U.S., 2005 – 2015
Chart 9-2: Market for Interventional Coronary Guidewires by Device Type, U.S., 2005 – 2015
Chart 9-3: Leading Competitors, Market for Interventional Coronary Guidewires, U.S., 2008
EMBOLIC PROTECTION DEVICES
Chart 10-1: Market for Coronary Embolic Protection Devices, U.S., 2005 – 2015133
Chart 10-2: Leading Competitors, Market for Coronary Embolic Protection Devices, U.S., 2008
CORONARY ATHERECTOMY DEVICES
Chart 11-1: Market for Coronary Atherectomy Devices, U.S., 2005 – 2015
Chart 11-2: Leading Competitors, U.S Market for Coronary Atherectomy Devices, 2008
THROMBECTOMY DEVICES
Chart 12-1: Market for Coronary Thrombectomy Devices, U.S., 2005 – 2015
Chart 12-2: Leading Competitors, Market for Coronary Thrombectomy Devices, U.S., 2008
CHRONIC TOTAL OCCLUSION CROSSERS
Chart 13-1: Market for Coronary Chronic Total Occlusion Crossers, U.S., 2005 – 2015
Chart 13-2: Penetration Rate, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2005 – 2015
Chart 13-3: Leading Competitors, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2008
INTRODUCER SHEATHS
Chart 14-1: Coronary Market for Introducer Sheaths, U.S., 2005 – 2015
Chart 14-2: Leading Competitors, U.S Market for Introducer Sheaths, 2008
VASCULAR CLOSURE DEVICES
Chart 15-1: Market for Coronary Vascular Closure Devices (Invasive and Non- Invasive), U.S., 2005 – 2015
Chart 15-2: Leading Competitors, Market for Coronary Vascular Closure Devices, U.S., 2008
DIAGNOSTIC CATHETERS AND GUIDEWIRES
Chart 16-1: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005 – 2015
Chart 16-2: Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Chart 16-3: Units Sold Segmented by Size, Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Chart 16-4: Leading Competitors, Market for Diagnostic Coronary Catheters, U.S., 2008
Chart 16-5: Market for Diagnostic Coronary Guidewires, U.S., 2005 – 2015
Chart 16-6: Leading Competitors, Market for Diagnostic Coronary Guidewires, U.S., 2008
Chart 16-7: Market for FFR Guidewires, U.S., 2005 – 2015
Chart 16-8: Leading Competitors in the FFR Guidewire Market, U.S., 2008
IVUS CATHETERS
Chart 17-1: Market for IVUS Catheters, U.S., 2005 – 2015
OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
Chart 18-1: Potential Market for OCT Catheters, U.S., 2010 – 2015
VULNERABLE PLAQUE DEVICES
Chart 19-1: Target Population, Potential Market for Vulnerable Plaque Screening, U.S., 2005 – 2015
Chart 19-2: Maximum Potential Market for Vulnerable Plaque, U.S., 2010 – 2015229
Chart 19-3: Forecasted Potential Market for Vulnerable Plaque, U.S., 2010 – 2015
Chart 19-4: Forecasted Potential Market for Vulnerable Plaque Screening, U.S., 2010 – 2015
Chart 19-5: Forecasted Potential Market for Vulnerable Plaque Treatment, U.S., 2010 – 2015
PFO DEVICES
Chart 20-1: Market for PFO Devices, U.S., 2005 – 2015
Chart 20-2: Leading Competitors, Market for PFO Devices, U.S., 2008
ASD AND VSD DEVICES
Chart 21-1: Market for ASD and VSD Devices, U.S., 2005 – 2015
Chart 21-2: Leading Competitors in the ASD and VSD Market, U.S., 2008
PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
Chart 22-1: Potential Market for Percutaneous Mitral Valve Repair Devices, U.S., 2010 – 2015
PERCUTANEOUS AORTIC HEART VALVE REPLACEMENT DEVICES
Chart 23-1: Revenue Probability, Potential Market for Aortic Valve Replacement Devices, U.S., 2008 – 2015
EXECUTIVE SUMMARY
1.1 MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
1.2 BARE-METAL AND DRUG-ELUTING STENTS
1.3 PTCA AND CUTTING BALLOONS
1.4 BALLOON-INFLATION SYRINGES AND ANGIOPLASTY KITS
1.5 INTERVENTIONAL CATHETERS
1.6 INTERVENTIONAL GUIDEWIRES
1.7 EMBOLIC PROTECTION DEVICES
1.8 ATHERECTOMY DEVICES
1.9 THROMBECTOMY DEVICES
1.10 CHRONIC TOTAL OCCLUSION CROSSERS
1.11 INTRODUCER SHEATHS.
1.12 VASCULAR CLOSURE DEVICES.
1.13 DIAGNOSTIC CORONARY CATHETERS AND GUIDEWIRES
1.14 FRACTIONAL FLOW RESERVE GUIDEWIRES
1.15 IVUS CATHETERS
1.16 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
1.17 VULNERABLE PLAQUE DEVICES
1.18 PFO, ASD AND VSD DEVICES
1.19 PERCUTANEOUS MITRAL VALVE REPAIR DEVICES.
1.20 AORTIC HEART VALVE REPLACEMENT DEVICES.
1.21 LEADING COMPETITORS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
2.2.1 Step 1: Project Initiation & Team Selection
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
2.2.4 Step 4: Performing Primary Research
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
2.2.6 Step 6: Market Forecast and Analysis
2.2.7 Step 7: Identify Strategic Opportunities
2.2.8 Step 8: Final Review and Market Release
2.2.9 Step 9: Customer Feedback and Market Monitoring
U.S MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
3.1 INTRODUCTION
3.2 OVERVIEW OF THE MARKET
3.3 MARKET SEGMENTED BY DEVICE TYPE
3.3.1 Effects of the Economic Crisis
3.4 TREND ANALYSIS BY MARKET SEGMENT
3.5 MARKET DRIVERS
3.6 MARKET LIMITERS
3.7 COMPETITIVE ANALYSIS
3.8 MERGERS AND ACQUISITIONS
BARE-METAL AND DRUG-ELUTING STENTS
4.1 INTRODUCTION
4.2 POPULATION AT RISK
4.3 PROCEDURE NUMBERS
4.4 MARKET ANALYSIS & FORECAST
4.4.1 Units Sold by Type
4.4.2 Bare-Metal Stent Market
4.4.2.1 Bare-Metal Stent Market Drivers
4.4.2.2 Bare-Metal Stent Market Limiters
4.4.3 Drug-Eluting Stent Market
4.4.3.1 Drug-Eluting Stent Market Drivers
4.4.3.2 Drug-Eluting Stent Market Limiters
4.4.4 Stents in Development
4.4.4.1 Bioabsorbable Stents
4.4.4.2 Bifurcated Stents
4.5 STENT MARKET BY DELIVERY PLATFORM.
4.6 STENT MARKET BY SIZE
4.7 COMPETITIVE ANALYSIS
4.7.1 Bare-Metal Stents
4.7.2 Drug-Eluting Stents
4.7.3 Potential New Market Participants
PTCA AND CUTTING BALLOON CATHETERS
5.1 INTRODUCTION
5.1.1 The Problem of Restenosis
5.1.2 Conventional and Cutting Balloons
5.2 MARKET OVERVIEW
5.3 MARKET FOR PTCA BALLOONS
5.3.1 Units Sold.
5.3.2 Market Analysis & Forecast
5.4 MARKET FOR CUTTING BALLOONS
5.4.1 Device Penetration
5.4.2 Market Analysis & Forecast
5.5 MARKET DRIVERS AND LIMITERS
5.5.1 Market Drivers
5.5.2 Market Limiters.
5.6 NEW TECHNOLOGIES – DRUG-COATED BALLOON CATHETERS
5.7 COMPETITIVE ANALYSIS
5.7.1 PTCA Balloon Catheters
5.7.2 Cutting Balloon Catheters
BALLOON-INFLATION SYRINGES
6.1 INTRODUCTION
6.2 MARKET ANALYSIS & FORECAST
6.3 MARKET DRIVERS AND LIMITERS
6.3.1 Market Drivers
6.3.2 Market Limiters
6.4 COMPETITIVE ANALYSIS
ANGIOPLASTY KITS
7.1 INTRODUCTION
7.2 MARKET ANALYSIS & FORECAST
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS
INTERVENTIONAL CATHETERS
8.1 INTRODUCTION
8.2 UNITS SOLD
8.3 MARKET ANALYSIS & FORECAST
8.3.1 Interventional Guiding Catheters Market.
8.3.2 Interventional Support Catheters Market
8.4 MARKET DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS
INTERVENTIONAL GUIDEWIRES
9.1 INTRODUCTION
9.1.1 Conventional and Specialty Guidewires
9.1.2 Material and Fabrication
9.2 UNITS SOLD
9.3 MARKET ANALYSIS & FORECAST
9.3.1 Conventional Guidewires Market
9.3.2 Specialized Guidewires Market
9.4 MARKET DRIVER AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS
EMBOLIC PROTECTION DEVICES
10.1 INTRODUCTION
10.1.1 Saphenous Vein Grafts
10.1.2 Protection Mechanism
10.2 MARKET ANALYSIS & FORECAST
10.3 PENETRATION RATE
10.4 MARKET DRIVERS AND LIMITERS
10.4.1 Market Drivers.
10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS
CORONARY ATHERECTOMY DEVICES
11.1 INTRODUCTION
11.1.1 Atherectomy
11.1.2 Technologies
11.1.2.1 Mechanical
11.1.2.2 Laser
11.1.2.3 Directional Coronary Atherectomy (DCA)
11.2 MARKET ANALYSIS & FORECAST
11.3 PENETRATION RATE
11.4 MARKET DRIVERS AND LIMITERS
11.4.1 Market Drivers.
11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS
THROMBECTOMY DEVICES
12.1 INTRODUCTION
12.1.1 Thrombosis and Drug-Eluting Stents
12.2 MARKET ANALYSIS & FORECAST
12.3 PENETRATION RATE
12.4 MARKET DRIVERS AND LIMITERS
12.4.1 Market Drivers.
12.4.2 Market Limiters
12.5 COMPETITIVE ANALYSIS
CHRONIC TOTAL OCCLUSION CROSSERS
13.1 INTRODUCTION
13.2 POTENTIAL MARKET.
13.3 MARKET ANALYSIS & FORECAST
13.4 PENETRATION RATE
13.5 MARKET DRIVERS AND LIMITERS
13.5.1 Market Drivers.
13.5.2 Market Limiters
13.6 COMPETITIVE ANALYSIS
INTRODUCER SHEATHS
14.1 INTRODUCTION
14.2 MARKET ANALYSIS & FORECAST
14.2.1 Units Sold
14.2.2 Market Analysis & Forecast
14.3 MARKET DRIVERS AND LIMITERS
14.3.1 Market Drivers.
14.3.2 Market Limiters
14.4 COMPETITIVE ANALYSIS
VASCULAR CLOSURE DEVICES
15.1 INTRODUCTION
15.1.1 Manual Compression
15.1.2 Invasive and Non-Invasive Devices
15.2 MARKET ANALYSIS & FORECAST
15.3 PENETRATION RATE
15.3.1 Diagnostic Procedures
15.3.2 Interventional Procedures
15.4 MARKET DRIVERS AND LIMITERS
15.4.1 Market Drivers.
15.4.2 Market Limiters
15.5 COMPETITIVE ANALYSIS
DIAGNOSTIC CATHETERS AND GUIDEWIRES
16.1 INTRODUCTION
16.1.1 Coronary Angiography
16.2 MARKET ANALYSIS & FORECAST
16.3 DIAGNOSTIC CATHETERS
16.3.1 Market Analysis & Forecast
16.3.2 Units Sold
16.3.3 Units Sold Segmented by Size
16.3.4 Competitive Analysis.
16.4 DIAGNOSTIC GUIDEWIRES
16.4.1 Market Analysis & Forecast
16.4.2 Units Sold
16.4.3 Competitive Analysis.
16.5 FRACTIONAL FLOW RESERVE (FFR) GUIDEWIRES
16.5.1 Market Analysis and Forecast
16.5.2 Units Sold
16.5.3 Competitive Analysis.
16.6 MARKET DRIVERS AND LIMITERS
16.6.1 Market Drivers.
16.6.2 Market Limiters
IVUS CATHETERS
17.1 INTRODUCTION
17.1.1 Pre-Stenting Applications
17.1.2 Post-Stenting Applications.
17.1.3 IVUS Console Penetration.
17.2 MARKET ANALYSIS & FORECAST
17.3 PENETRATION RATE
17.4 MARKET DRIVERS AND LIMITERS
17.4.1 Market Drivers.
17.4.2 Market Limiters
17.5 COMPETITIVE ANALYSIS
OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
18.1 INTRODUCTION
18.2 POTENTIAL MARKET.
18.3 MARKET ANALYSIS AND FORECAST
18.4 MARKET DRIVERS AND LIMITERS
18.4.1 Market Drivers.
18.4.2 Market Limiters
18.5 COMPETITIVE ANALYSIS
VULNERABLE PLAQUE DEVICES
19.1 INTRODUCTION
19.1.1 Vulnerable Plaque Screening Technologies
19.1.1.1 Intravascular Ultrasound (IVUS)
19.1.1.2 Optical Coherence Tomography (OCT)
19.1.1.3 Raman Spectroscopy
19.1.1.4 Near Infrared (NIR) Spectroscopy
19.1.1.5 Thermography
19.1.1.6 Intravascular Magnetic Resonance Imaging (IVMRI)
19.1.1.7 Computed Tomography (CT)
19.1.2 Potential Vulnerable Plaque Treatments
19.1.2.1 Stents
19.1.2.2 Pharmaceuticals
19.1.2.3 Photodynamic Therapies
19.1.2.4 Cryotherapy
19.2 TARGET POPULATION
19.3 MARKET ANALYSIS AND FORECAST
19.3.1 Total Market Potential.
19.3.2 Market Forecast
19.3.3 Screening Market
19.3.4 Treatment Market
19.4 COMPETITIVE ANALYSIS
PFO DEVICES
20.1 INTRODUCTION
20.2 MARKET ANALYSIS AND FORECAST
20.3 MARKET DRIVERS AND LIMITERS
20.3.1 Market Drivers.
20.3.2 Market Limiters
20.4 COMPETITIVE ANALYSIS
ASD AND VSD DEVICES
21.1 INTRODUCTION
21.1.1 Atrial Septal Defect (ASD)248
21.1.2 Ventricular Septal Defect (VSD)248
21.2 MARKET ANALYSIS AND FORECAST
21.3 MARKET DRIVERS AND LIMITERS
21.3.1 Market Drivers.
21.3.2 Market Limiters
21.4 COMPETITIVE ANALYSIS
PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
22.1 INTRODUCTION
22.1.1 Percutaneous Mitral Valve Repair (PMVR)
22.2 TARGET POPULATION
22.3 POTENTIAL MARKET.
22.4 MARKET DRIVERS AND LIMITERS
22.4.1 Market Drivers.
22.4.2 Limiters
22.5 COMPETITIVE ANALYSIS
PERCUTANEOUS AORTIC HEART VALVE REPLACEMENT DEVICES
23.1 INTRODUCTION
23.2 MARKET ANALYSIS AND FORECAST
23.2.1 Revenue Probability
23.3 MARKET DRIVERS AND LIMITERS
23.3.1 Market Drivers.
23.3.2 Market Limiters
23.4 COMPETITIVE ANALYSIS
LIST OF FIGURES
EXECUTIVE SUMMARY
RESEARCH METHODOLOGY.
U.S MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES.
Figure 3-1: Market for Interventional Cardiology Segmented by Device Type, U.S., 2005 – 2015
Figure 3-2: Trend Analysis by Market Segment, Growth Rates of the Market for Interventional Cardiology, U.S., 2005 – 2015
Figure 3-3: Market Drivers, Market for Interventional Cardiology, U.S, 2008
Figure 3-4: Market Limiters, Market for Interventional Cardiology, U.S., 2008
Figure 3-5: Leading Competitors by Market Segment, U.S Market for Interventional Cardiology, 2008
BARE-METAL AND DRUG-ELUTING STENTS.
Figure 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005 – 2015
Figure 4-2: Angiography and Angioplasty Procedures, U.S., 2005 – 2015
Figure 4-3: Market for Coronary Stents by Type, U.S., 2005 – 2015.
Figure 4-4: Units Sold, Market for Coronary Stents, U.S., 2005 – 2015
Figure 4-5: Coronary Stent Units by Type, U.S., 2005 – 2015
Figure 4-6: Market for Bare-Metal Stents, U.S., 2005 – 2015
Figure 4-7: Market Drivers and Limiters, Market for Bare-Metal Stents, U.S., 2008
Figure 4-8: Market for Drug-Eluting Stents, U.S., 2005 – 2015
Figure 4-9: Market Drivers and Limiters, Market for Drug-Eluting Stents, U.S., 2008
Figure 4-10: Coronary Stent Platforms in Development Not Approved by the FDA, 2008.
Figure 4-11: Potential Market for Bioabsorbable Stents, U.S., 2013 – 2015
Figure 4-12: Potential Market for Bifurcated Stents, U.S., 2010 – 2015
Figure 4-13: Market for Coronary Stents by Delivery Platform, Units Sold, U.S., 2005 – 2015
Figure 4-14: Market for Coronary Stents by Size, U.S., 2008
Figure 4-15: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
Figure 4-16: Leading Competitors, U.S Market for Drug-Eluting Stents, 2008
PTCA AND CUTTING BALLOON CATHETERS
Figure 5-1: Market for PTCA and Cutting Balloon Catheters, U.S., 2005 – 2015
Figure 5-2: Units Sold, Market for PTCA Balloon Catheters, U.S., 2005 – 2015
Figure 5-3: Market for PTCA Balloon Catheters, U.S., 2005 – 2015
Figure 5-4: Units Sold, Market for Cutting Balloon Catheters, U.S., 2005 – 2015
Figure 5-5: Market for Cutting Balloon Catheters, U.S., 2005 – 2015
Figure 5-6: Market Drivers and Limiters, U.S Market for PTCA and Cutting Balloon Catheters, 2008
Figure 5-7: Leading Competitors, Market for PTCA Balloon Catheters, U.S., 2008
Figure 5-8: Leading Competitors, Market for PTCA Balloon Catheters, U.S., 2008
BALLOON-INFLATION SYRINGES.
Figure 6-1: Market for Balloon-Inflation Syringes, U.S., 2005 – 2015
Figure 6-2: Market Drivers and Limiters, U.S Market for Balloon-Inflation Syringes, 2008
Figure 6-3: Leading Competitors, Market for Balloon-Inflation Syringes, U.S., 2008
ANGIOPLASTY KITS
Figure 7-1: Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
Figure 7-2: Market Drivers and Limiters, Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
Figure 7-3: Leading Competitors, Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
INTERVENTIONAL CATHETERS
Figure 8-1: Units Sold, Market for Interventional Coronary Catheters, U.S., 2005 – 2015
Figure 8-2: Market for Interventional Coronary Catheters by Device Type, U.S., 2005 – 2015
Figure 8-3: Market for Interventional Guiding Catheters, U.S., 2005 – 2015
Figure 8-4: Market for Interventional Support Catheters, U.S., 2005 – 2015
Figure 8-5: Market Drivers and Limiters, Market for Interventional Coronary Catheters, U.S., 2008
Figure 8-6: Leading Competitors, Market for Interventional Coronary Catheters, U.S., 2008
INTERVENTIONAL GUIDEWIRES
Figure 9-1: Units Sold, Market for Interventional Coronary Guidewires, U.S., 2005 – 2015
Figure 9-2: Market for Interventional Coronary Guidewires by Device Type, U.S., 2005 – 2015
Figure 9-3: Market for Interventional Coronary Conventional Guidewires, U.S., 2005 – 2015
Figure 9-4: Market for Interventional Coronary Specialized Guidewires, U.S., 2005 – 2015
Figure 9-5: Market Drivers and Limiters, Market for Interventional Coronary Guidewires, U.S., 2008
Figure 9-6: Leading Competitors, Market for Interventional Coronary Guidewires, U.S., 2008
EMBOLIC PROTECTION DEVICES
Figure 10-1: Market for Coronary Embolic Protection Devices, U.S., 2005 – 2015132
Figure 10-2: Penetration Rate, Market for Coronary Embolic Protection Devices, U.S., 2005 – 2015
Figure 10-3: Market Drivers and Limiters, Market for Coronary Embolic Protection Devices, U.S., 2008
Figure 10-4: Leading Competitors, Market for Coronary Embolic Protection Devices, U.S., 2008
CORONARY ATHERECTOMY DEVICES
Figure 11-1: Market for Coronary Atherectomy Devices, U.S., 2005 – 2015
Figure 11-2: Penetration Rate, Market for Coronary Atherectomy Devices, U.S., 2005 – 2015
Figure 11-3: Market Drivers and Limiters, U.S Market for Coronary Atherectomy Devices, 2008
Figure 11-4: Leading Competitors, Market for Coronary Atherectomy Devices, U.S., 2008
THROMBECTOMY DEVICES
Figure 12-1: Market for Coronary Thrombectomy Devices, U.S., 2005 – 2015
Figure 12-2: Penetration Rate, Market for Coronary Thrombectomy Devices, U.S., 2005 – 2015
Figure 12-3: Market Drivers and Limiters, Market for Coronary Thrombectomy Devices, U.S., 2008
Figure 12-4: Leading Competitors, Market for Coronary Thrombectomy Devices, U.S., 2008
CHRONIC TOTAL OCCLUSION CROSSERS
Figure 13-1: Potential Market for Chronic Total Occlusion Crossers, Market for Interventional Cardiology, U.S., 2005 – 2015
Figure 13-2: Market for Coronary Chronic Total Occlusion Crossers, U.S., 2005 – 2015
Figure 13-3: Penetration Rate, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2005 – 2015
Figure 13-4 Market Drivers and Limiters, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2008
Figure 13-5: Leading Competitors, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2008
INTRODUCER SHEATHS
Figure 14-1: Units Sold, Coronary Market for Introducer Sheaths, U.S., 2005 – 2015
Figure 14-2: Coronary Market for Introducer Sheaths, U.S., 2005 – 2015
Figure 14-3: Market Drivers and Limiters, U.S Market for Introducer Sheaths, 2008
Figure 14-4: Leading Competitors, Market for Introducer Sheaths, U.S., 2008
VASCULAR CLOSURE DEVICES
Figure 15-1: Market for Coronary Vascular Closure Devices (Invasive and Non- Invasive), U.S., 2005 – 2015
Figure 15-2: Penetration Rate, Market for Coronary Vascular Closure Devices (Invasive and Non-Invasive), U.S., 2005 – 2015
Figure 15-3: Market Drivers and Limiters, Market for Coronary Vascular Closure Devices, U.S., 2008
Figure 15-4: Leading Competitors, Market for Coronary Vascular Closure Devices, U.S., 2008
DIAGNOSTIC CATHETERS AND GUIDEWIRES
Figure 16-1: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005 – 2015
Figure 16-2: Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Figure 16-3: Units Sold, Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Figure 16-4: Units Sold Segmented by Size, Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Figure 16-5: Leading Competitors, Market for Diagnostic Coronary Catheters, U.S., 2008
Figure 16-6: Market for Diagnostic Coronary Guidewires, U.S., 2005 – 2015
Figure 16-7: Units Sold, Market for Diagnostic Coronary Guidewires, U.S., 2005 – 2015
Figure 16-8: Leading Competitors, Market for Diagnostic Coronary Guidewires, U.S., 2008
Figure 16-9: Market for FFR Guidewires, U.S., 2005 – 2015.
Figure 16-10: Units Sold, Market for FFR Guidewires, U.S., 2005 – 2015
Figure 16-11: Leading Competitors in the FFR Guidewire Market, U.S., 2008
Figure 16-12: Market Drivers and Limiters, Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2008
IVUS CATHETERS
Figure 17-1: IVUS Console Penetration Rate, U.S., 2005 – 2015
Figure 17-2: Market for IVUS Catheters, U.S., 2005 – 2015
Figure 17-3: Penetration Rate, Market for IVUS Catheters, U.S., 2005 – 2015
Figure 17-4: Market Drivers and Limiters, Market for IVUS Catheters, U.S., 2008210
Figure 17-5: Leading Competitors, Market for IVUS Catheters, U.S., 2005 – 2015211
OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
Figure 18-1: Potential Market for OCT Catheters, U.S., 2010 – 2015.
Figure 18-2: Potential Market for OCT Consoles, U.S., 2010 – 2015
Figure 18-3: Potential Market for Coronary OCT Devices, U.S., 2010 – 2015
Figure 18-4: Market Drivers and Limiters in the OCT Market, U.S., 2008
VULNERABLE PLAQUE DEVICES
Figure 19-1: Target Population, Potential Market for Vulnerable Plaque Screening, U.S., 2005 – 2015
Figure 19-2: Maximum Potential Market for Vulnerable Plaque, U.S., 2010 – 2015
Figure 19-3: Forecasted Potential Market for Vulnerable Plaque, U.S., 2010 – 2015
Figure 19-4: Forecasted Potential Market for Vulnerable Plaque Screening, U.S., 2010 – 2015
Figure 19-5 : Forecasted Potential Market for Vulnerable Plaque Treatment, U.S., 2010 – 2015
Figure 19-6: Potential Competitors in the U.S Market for Vulnerable Plaque Devices
PFO DEVICES
Figure 20-1: Market for PFO Devices, U.S., 2005 – 2015
Figure 20-2: Market Drivers and Limiters in the PFO Devices Market, U.S., 2008244
Figure 20-3: Leading Competitors, Market for PFO Devices, U.S., 2008
ASD AND VSD DEVICES
Figure 21-1: Market for ASD and VSD Devices, U.S., 2005 – 2015
Figure 21-2: Market Drivers and Limiters in the ASD and VSD Devices Market, U.S., 2008
Figure 21-3: Leading Competitors, Market for ASD and VSD Devices, U.S., 2008253
PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
Figure 22-1: Target Population, Potential Market for PMVR Devices, U.S., 2010 – 2015
Figure 22-2: Potential Market for Percutaneous Mitral Valve Repair Devices, U.S., 2010 – 2015
Figure 22-3: Market Drivers and Limiters in the PVMR Market, U.S., 2008
Figure 22-4: Market Players, Potential Market for PMVR Devices, U.S., 2010 – 2015
PERCUTANEOUS AORTIC HEART VALVE REPLACEMENT DEVICES
Figure 23-1: Potential Market for Aortic Valve Replacement Devices, Weighted Average Scenario, U.S., 2008 – 2015
Figure 23-2: Total Revenue, Potential Market for Aortic Valve Replacement Devices, Weighted Average Scenario, U.S., 2011 – 2015
Figure 23-3: Market Drivers and Limiters in the Aortic Valve Replacement Market, U.S., 2008
Figure 23-4: Market Players, Potential Market for PAVR Devices, U.S., 2010 – 2015
LIST OF CHARTS
EXECUTIVE SUMMARY
Chart 1-1: Market for Interventional Cardiology Devices, U.S., 2008
Chart 1-2: Market for Coronary Stents, U.S., 2005 – 2015
Chart 1-3: Coronary Atherectomy Devices Market, U.S., 2005 – 2015
Chart 1-4: Coronary CTO Crosser Market, U.S., 2005 – 2015
Chart 1-5: Coronary Vascular Closure Devices, U.S., 2005 – 2015
Chart 1-6: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005 – 2015
Chart 1-7: Penetration Rate of FFR Guidewires in PCI Procedures, U.S., 2005 - 2015
Chart 1-8: Number of IVUS Catheter Units Sold, U.S., 2005 – 2015
Chart 1-9: Optical Coherence Tomography Catheter Market, U.S., 2010 – 2015
Chart 1-10: Leading Competitors, Market for Interventional Cardiology, U.S., 2008
RESEARCH METHODOLOGY.
U.S MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES.
Chart 3-1: Market for Interventional Cardiology, U.S., 2005 – 2015
Chart 3-2: Market for Interventional Cardiology Segmented by Device Type, U.S., 2008
Chart 3-3: Market for Interventional Cardiology Segmented by Device Type, U.S., 2015
Chart 3-4: Trend Analysis for Selected Markets for Interventional Cardiology Devices, U.S., 2005 – 2015
Chart 3-5: Leading Competitors, Market for Interventional Cardiology, U.S., 2008
BARE-METAL AND DRUG-ELUTING STENTS.
Chart 4-1: Population at Risk, Market for Interventional Cardiology, U.S., 2005 – 2015
Chart 4-2: Age Group Most Likely to Undergo Cardiac Intervention: 60 to 69 Years Old, U.S., 2005 – 2015
Chart 4-3: Angioplasty and Angiography Procedures, U.S., 2005 – 2015
Chart 4-4: Market for Coronary Stents by Type, U.S., 2005 – 2015
Chart 4-5: Coronary Stent Units by Type, U.S., 2005 – 2015
Chart 4-6: Market for Bare-Metal Stents, U.S., 2005 – 2015.
Chart 4-7: Market for Drug-Eluting Stents, U.S., 2005 – 2015.
Chart 4-8: Penetration Rate for Bioabsorbable Stents, U.S., 2013 – 2015
Chart 4-9: Penetration Rate for Bifurcated Stents, U.S., 2010 – 2015
Chart 4-10: Market for Coronary Stents by Delivery Platform, Units Sold, U.S., 2005 – 2015
Chart 4-11: Market for Coronary Stents by Size, U.S., 2008
Chart 4-12: Leading Competitors, Market for Bare-Metal Stents, U.S., 2008
Chart 4-13: Leading Competitors, Market for Drug-Eluting Stents, U.S., 2008
PTCA AND CUTTING BALLOON CATHETERS
Chart 5-1: Market for PTCA and Cutting Balloon Catheters, U.S., 2005 – 2015
Chart 5-2: Market for PTCA Balloon Catheters, U.S., 2005 – 2015
Chart 5-3: Market for Cutting Balloon Catheters, U.S., 2005 – 2015.
Chart 5-4: Leading Competitors, Market for PTCA Balloon Catheters, U.S., 200896
BALLOON-INFLATION SYRINGES.
Chart 6-1: Market for Balloon-Inflation Syringes, U.S., 2005 – 2015.
Chart 6-2: Leading Competitors, Market for Balloon-Inflation Syringes, U.S., 2008
ANGIOPLASTY KITS
Chart 7-1: Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
Chart 7-2: Leading Competitors, Market for Angioplasty Accessory Kits, U.S., 2005 – 2015
INTERVENTIONAL CATHETERS
Chart 8-1: Market for Interventional Coronary Catheters by Device Type, U.S., 2005 – 2015
Chart 8-2: Leading Competitors, Market for Interventional Coronary Catheters, U.S., 2008
INTERVENTIONAL GUIDEWIRES
Chart 9-1: Units Sold, Market for Interventional Coronary Guidewires, U.S., 2005 – 2015
Chart 9-2: Market for Interventional Coronary Guidewires by Device Type, U.S., 2005 – 2015
Chart 9-3: Leading Competitors, Market for Interventional Coronary Guidewires, U.S., 2008
EMBOLIC PROTECTION DEVICES
Chart 10-1: Market for Coronary Embolic Protection Devices, U.S., 2005 – 2015133
Chart 10-2: Leading Competitors, Market for Coronary Embolic Protection Devices, U.S., 2008
CORONARY ATHERECTOMY DEVICES
Chart 11-1: Market for Coronary Atherectomy Devices, U.S., 2005 – 2015
Chart 11-2: Leading Competitors, U.S Market for Coronary Atherectomy Devices, 2008
THROMBECTOMY DEVICES
Chart 12-1: Market for Coronary Thrombectomy Devices, U.S., 2005 – 2015
Chart 12-2: Leading Competitors, Market for Coronary Thrombectomy Devices, U.S., 2008
CHRONIC TOTAL OCCLUSION CROSSERS
Chart 13-1: Market for Coronary Chronic Total Occlusion Crossers, U.S., 2005 – 2015
Chart 13-2: Penetration Rate, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2005 – 2015
Chart 13-3: Leading Competitors, Market for Coronary Chronic Total Occlusion Crossers, U.S., 2008
INTRODUCER SHEATHS
Chart 14-1: Coronary Market for Introducer Sheaths, U.S., 2005 – 2015
Chart 14-2: Leading Competitors, U.S Market for Introducer Sheaths, 2008
VASCULAR CLOSURE DEVICES
Chart 15-1: Market for Coronary Vascular Closure Devices (Invasive and Non- Invasive), U.S., 2005 – 2015
Chart 15-2: Leading Competitors, Market for Coronary Vascular Closure Devices, U.S., 2008
DIAGNOSTIC CATHETERS AND GUIDEWIRES
Chart 16-1: Market for Diagnostic Coronary Catheters and Guidewires, U.S., 2005 – 2015
Chart 16-2: Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Chart 16-3: Units Sold Segmented by Size, Market for Diagnostic Coronary Catheters, U.S., 2005 – 2015
Chart 16-4: Leading Competitors, Market for Diagnostic Coronary Catheters, U.S., 2008
Chart 16-5: Market for Diagnostic Coronary Guidewires, U.S., 2005 – 2015
Chart 16-6: Leading Competitors, Market for Diagnostic Coronary Guidewires, U.S., 2008
Chart 16-7: Market for FFR Guidewires, U.S., 2005 – 2015
Chart 16-8: Leading Competitors in the FFR Guidewire Market, U.S., 2008
IVUS CATHETERS
Chart 17-1: Market for IVUS Catheters, U.S., 2005 – 2015
OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICES
Chart 18-1: Potential Market for OCT Catheters, U.S., 2010 – 2015
VULNERABLE PLAQUE DEVICES
Chart 19-1: Target Population, Potential Market for Vulnerable Plaque Screening, U.S., 2005 – 2015
Chart 19-2: Maximum Potential Market for Vulnerable Plaque, U.S., 2010 – 2015229
Chart 19-3: Forecasted Potential Market for Vulnerable Plaque, U.S., 2010 – 2015
Chart 19-4: Forecasted Potential Market for Vulnerable Plaque Screening, U.S., 2010 – 2015
Chart 19-5: Forecasted Potential Market for Vulnerable Plaque Treatment, U.S., 2010 – 2015
PFO DEVICES
Chart 20-1: Market for PFO Devices, U.S., 2005 – 2015
Chart 20-2: Leading Competitors, Market for PFO Devices, U.S., 2008
ASD AND VSD DEVICES
Chart 21-1: Market for ASD and VSD Devices, U.S., 2005 – 2015
Chart 21-2: Leading Competitors in the ASD and VSD Market, U.S., 2008
PERCUTANEOUS MITRAL VALVE REPAIR DEVICES
Chart 22-1: Potential Market for Percutaneous Mitral Valve Repair Devices, U.S., 2010 – 2015
PERCUTANEOUS AORTIC HEART VALVE REPLACEMENT DEVICES
Chart 23-1: Revenue Probability, Potential Market for Aortic Valve Replacement Devices, U.S., 2008 – 2015
